Rein Therapeutics (RNTX) Non-Current Assets (2016 - 2026)
Rein Therapeutics (RNTX) recorded Non-Current Assets of $24.52 million in Q2 2026, down 51.8% from $50.88 million a year earlier but up 17.7% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Rein Therapeutics reported Non-Current Assets of $19.83 million, down 59.1% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 321.0% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $48.53 million in FY2024 (-44.7%), $87.74 million in FY2023, $134,000 in FY2022 (-55.9%) and $304,000 in FY2021.
- Quarterly Non-Current Assets has ranged from $29,000 in Q3 2023 to $87.74 million in Q4 2023 over the past five years.
- On a year-over-year basis, Non-Current Assets has declined for seven consecutive quarters, with an average decline of 48.7% over the last seven quarters.
- The year-over-year decline in Non-Current Assets has ranged between 24.5% (Q1 2022) and 94.5% (Q3 2021) over the last five years.
- Per Business Quant, the preceding three quarters came in at $20.84 million (Q1 2026), $19.83 million (Q4 2025) and $48.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - | 24.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.52 Mn |
| Mar 31, 2026 | 20.84 Mn |
| Dec 31, 2025 | 19.83 Mn |
| Sep 30, 2025 | 48.53 Mn |
| Jun 30, 2025 | 50.88 Mn |
| Mar 31, 2025 | 49.30 Mn |
| Dec 31, 2024 | 48.53 Mn |
| Sep 30, 2024 | 85.53 Mn |
| Jun 30, 2024 | 86.24 Mn |
| Mar 31, 2024 | 86.43 Mn |
| Dec 31, 2023 | 87.74 Mn |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 134,000.00 |
| Sep 30, 2022 | 178,000.00 |
| Jun 30, 2022 | 220,000.00 |
| Mar 31, 2022 | 262,000.00 |
| Dec 31, 2021 | 304,000.00 |
| Sep 30, 2021 | 345,000.00 |
API Access
Rein Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();